Correlations between obesity antropometric markers, adipocytokines and monocytes oxidative stress status in type 2 diabetic patients

Farmacia

Volumn 60, Issue 2, 2012, Pages 194-205

  Bǎcanu, Elena Violeta ^a   Lixandru, Daniela ^b,c   Stoian, Irina ^b   Vîrgolici, Bogdana ^b   Mohora, Maria ^b   Arsene, Andreea Letitia ^b   Ionescu Tîrgovişte, Constantin ^a  

^a Nutrition and Metabolic Diseases   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c INSTITUTE OF BIOCHEMISTRY OF THE ROMANIAN ACADEMY   (Romania)

Author keywords

Adipocytokines; Monocyte; NADPH oxidase; Paraoxonase2

Indexed keywords

ADIPONECTIN; ALBUMIN; ARYLDIALKYLPHOSPHATASE 2; LEPTIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADIPOCYTE; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS;

EID: 84869022871     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Brownlee M., The Pathobiology of Diabetic Complications: A Unifying Mechanism, Diabetes, 2005, 54(6), 1615-1625
2. Kannel W., McGee D., Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study, Diabetes Care, 1979, 2(2), 120-126
3. Haffner S.M., Lehto S., Ronnemaa T., Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N Engl J Med, 1998, 339, 229-234
4. Libby P., Inflammation in atherosclerosis, Nature, 2002, 420(6917), 868-874
5. Napoli C., dNFPW., Multiple role of reactive oxygen species in the arterial wall, Journal of Cellular Chemistry, 2001, 82, 674-682
6. Moreno P.R., Murcia A.M., Palacios I.F., Leon M.N., Bernardi V.H., Fuster V., Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus, Circulation, 2000, 102(18), 2180-2184
7. Kitahara M., Eyre H.J., Lynch R.E., Rallison M.L., Hill H.R., Metabolic activity of diabetic monocytes, Diabetes, 1980, 29(4), 251-256
8. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., Oxidative damage to DNA in diabetes mellitus, Lancet, 1996, 347(8999), 444-445
9. Hiramatsu K., Arimori S., Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes, Diabetes, 1988, 37(6), 832-837
10. Miricescu D., Greabu M., Totan A., Mohora M., Didilescu A., Mitrea N., Arsene A., Spinu T., Totan C., Rǎdulescu R., Oxidative stress-a possible link between systemic and oral diseases, Farmacia, 2011, 59(3), 329-337
11. Tripathy D., Mohanty P., Dhindsa S., Syed T., Ghanim H., Aljada A., Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects, Diabetes, 2003, 52(12), 2882-2887
12. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., Dandona P., Glucose Challenge Stimulates Reactive Oxygen Species (ROS) Generation by Leucocytes, J Clin Endocrinol Metab, 2000, 85(8), 2970-2973
13. Mackness B., Durrington P.N., Mackness M.I., The paraoxonase gene family and coronary heart disease, Curr Opin Lipidol, 2002, 13(4), 357-362
14. Aviram M., Rosenblat M., Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development, Free Radic Biol Med, 2004, 37(9), 1304-1316
15. Stocker R., Keaney J.F., Role of oxidative modifications in atherosclerosis, Physiol Rev, 2004, 84(4), 1381-1478
16. Aviram M., Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 2000; 33 Suppl: S85-S97.
17. Steinberg D., Low density lipoprotein oxidation and its pathobiological significance, J Biol Chem, 1997, 272(34), 20963-20966
18. Rozenberg O., Rosenblat M., Coleman R., Shih D.M., Aviram M., Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice, Free Radic Biol Med, 2003, 34(6), 774-784
19. Getz G.S., Reardon C.A., Paraoxonase, a cardioprotective enzyme: continuing issues, Curr Opin Lipidol, 2004, 15(3), 261-267
20. Rozenberg O., Shih D.M., Aviram M., Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice, Atherosclerosis, 2005, 181(1), 9-18
21. Aviram M., Rosenblat M., Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences, Curr Opin Lipidol, 2005, 16(4), 393-399
22. Rosenblat M., Draganov D., Watson C.E., Bisgaier C.L., La Du B.N., Aviram M., Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress, Arterioscler Thromb Vasc Biol, 2003, 23(3), 468-474
23. Ng C.J., Wadleigh D.J., Gangopadhyay A., Hama S., Grijalva V.R., Navab M., Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cellmediated Oxidative Modification of Low Density Lipoprotein, J Biol Chem, 2001, 276(48), 44444-44449
24. Rosenblat M., Hayek T., Hussein K., Aviram M., Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy, Arterioscler Thromb Vasc Biol, 2004, 24(1), 175-180
25. Kershaw E.E., Flier J.S., Adipose Tissue as an Endocrine Organ, Journal of Clinical Endocrinology & Metabolism, 2004, 89(6), 2548-2556
26. Trayhurn P., Adipocyte biology, Obesity Reviews, 2007, 8, 41-44
27. Margetic S., Gazzola C., Pegg G.G., Hill R.A., Leptin: a review of its peripheral actions and interactions, Int J Obes Relat Metab Disord, 2002, 26(11), 1407-1433
28. Seufert J., Leptin Effects on Pancreatic +{pipe}-Cell Gene Expression and Function, Diabetes, 2004, 53 (suppl 1), S152-S158
29. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome, J Clin Invest, 2006, 116(7), 1784-1792
30. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-+{pipe}B Signaling Through a cAMP-Dependent Pathway, Circulation, 2000, 102(11), 1296-1301
31. American Diabetes Association. Standards of Medical Care in Diabetes 2011, Diabetes Care, 2011, 34 (Supplement 1), S11-S61
32. Friedewald W.T., Levy M., Frederickson D.S., Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge, Clin Chem, 1972, 18, 499-502
33. Allen R.C., Loose L.D., Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages, Biochemical and biophysical research communications, 1976, 69(1), 245-252
34. Bradford M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 1976, 72, 248-254
35. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., La Du B.N., Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation, J Biol Chem, 2000, 275(43), 33435-33442
36. Paulescu N., Traité de Physiologie Medicale, 1920, vol 2, Bucharest
37. Ionescu-Tîrgovişte C., Cheţa D., Popa E., Mincu I., Le rôle de lobesité dans letiopatogenie du diabète sucré, Medecine et Nutrition, 1976, 12, 97-106
38. Wellen K.E., Hotamisligil G.S., Obesity-induced inflammatory changes in adipose tissue, J Clin Invest, 2003, 112(12), 1785-1788
39. Ito A., Suganami T., Yamauchi A., Gawa-Yamauchi M., Tanaka M., Kouyama R., Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue, J Biol Chem, 2008, 283(51), 35715-35723
40. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda.M., Shimomura I., Increased oxidative stress in obesity and its impact on metabolic syndrome, J Clin Invest, 2004, 114(12), 1752-1761
41. Fontana L., Eagon J.C., Trujillo M.E., Scherer P.E., Klein S., Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans, Diabetes, 2007, 56(4), 1010-1013
42. Yuan H., Lu Y., Huang X., He Q., Man Y., Zhou Y., Suppression of NADPH oxidase 2 substantially restores glucose-induced dysfunction of pancreatic NIT-1 cells, FEBS J, 2010, 277(24), 5061-5071
43. Lee Y.W., Lee W.H., Kim P.H., Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium, Inflamm Res, 2010, 59(9), 755-765
44. Guzik J., Mangalat D., Korbut R., Adipocytokines-novel link between inflammation and vascular function?, Journal of Physiology and Pharmacology, 2006, 57(4), 505-528
45. Virgolici B., Mohora M., Radoi V., Lixandru D., Stoian I., Gaman L., Coman A., Greabu M., Manuel-y-Keenoy B., Correlations between dysglycemia, markers of oxidative stress and inflammation in diabetic foot patients, Farmacia, 2011, 59 (2), 216-226
46. Lum H., Roebuch A., Oxidant stress and endothelial cell dysfunction, Am J Physiol Cell Physiol, 2001, 280 (4), 719-741
47. Milsom A.B., Abnormal metabolic fate of nitric oxide in type 2 diabetes mellitus, Diabetologia, 2002, 45, 1515-1522
48. Rippin J.D., Nitric oxide synthase gene polymorphisms and diabetic nephropathy, Diabetologia, 2003, 46, 426-428
49. Spitaler M.M., Graier W.F., Vascular targets of redox signaling in diabetes mellitus, Diabetologia, 2002, 45, 476-494
50. Miricescu D., Greabu M., Totan A., Mohora M., Didilescu A., Mitrea N., Arsene A., Spinu T., Totan C., Rǎdulescu R., Oxidative Stress-A possible link between systemic and oral diseases, Farmacia, 2011, 59 (3), 329-337
51. Poulsen P.L., Hansen K.W., Mogensen C.E., Ambulatory blood pressure in the transition from normo-to microalbuminuria: a longitudinal study in IDDM patients, Diabetes, 1994, 43, 1248-1253
52. Nourooz-Zadeh J., Rahimi A., Tajaddini-Sarmadi J., Relationship between plasma measures of oxidative stress and metabolic control in NIDDM, Diabetologia, 1997, 40, 647-653